Pro Medicus Ltd (AU:PME) — Market Cap & Net Worth
Market Cap & Net Worth: Pro Medicus Ltd (PME)
Pro Medicus Ltd (AU:PME) has a market capitalization of $11.80 Billion (AU$16.68 Billion) as of June 4, 2026. Listed on the AU stock exchange, this Australia-based company holds position #1986 globally and #41 in its home market, demonstrating a 25.38% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Pro Medicus Ltd's stock price AU$159.63 by its total outstanding shares 104469963 (104.47 Million). Review debt load of Pro Medicus Ltd to assess the company's total debt and financial obligations.
Pro Medicus Ltd Market Cap History: 2015 to 2026
Pro Medicus Ltd's market capitalization history from 2015 to 2026. Data shows growth from $236.64 Million to $11.80 Billion (44.65% CAGR).
Index Memberships
Pro Medicus Ltd is a constituent of 8 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Australia All Ordinaries
AORD
|
$1.99 Trillion | 0.59% | #35 of 495 |
|
S&P/ASX 100
ATOI
|
$1.84 Trillion | 0.64% | #35 of 100 |
|
S&P/ASX All Australian 200
AXAT
|
$1.90 Trillion | 0.62% | #33 of 200 |
|
S&P/ASX 200
AXJO
|
$1.86 Trillion | 0.63% | #34 of 200 |
|
S&P/ASX 200 Accumulated
AXJOA
|
$1.86 Trillion | 0.63% | #34 of 200 |
|
S&P/ASX 300
AXKO
|
$2.14 Trillion | 0.55% | #37 of 300 |
|
S&P/ASX Midcap 50
AXMD
|
$238.57 Billion | 4.95% | #4 of 50 |
|
S&P/ASX All Technology
AXTX
|
$111.51 Billion | 10.58% | #3 of 53 |
Weight: Pro Medicus Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Pro Medicus Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Pro Medicus Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
76.68x
Pro Medicus Ltd's market cap is 76.68 times its annual revenue
Latest Price to Earnings (P/E) Ratio
141.70x
Pro Medicus Ltd's market cap is 141.70 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $341.61 Million | $27.52 Million | $6.37 Million | 12.41x | 53.64x |
| 2017 | $625.75 Million | $31.60 Million | $9.32 Million | 19.80x | 67.13x |
| 2018 | $785.65 Million | $35.92 Million | $9.96 Million | 21.87x | 78.84x |
| 2019 | $1.62 Billion | $50.10 Million | $19.12 Million | 32.31x | 84.65x |
| 2020 | $2.49 Billion | $56.82 Million | $23.08 Million | 43.78x | 107.80x |
| 2021 | $4.56 Billion | $67.88 Million | $30.85 Million | 67.18x | 147.82x |
| 2022 | $4.05 Billion | $93.46 Million | $44.44 Million | 43.37x | 91.21x |
| 2023 | $7.06 Billion | $124.90 Million | $60.65 Million | 56.53x | 116.42x |
| 2024 | $18.49 Billion | $161.43 Million | $82.79 Million | 114.53x | 223.31x |
| 2025 | $16.33 Billion | $212.91 Million | $115.22 Million | 76.68x | 141.70x |
Competitor Companies of PME by Market Capitalization
Companies near Pro Medicus Ltd in the global market cap rankings as of June 4, 2026.
Key companies related to Pro Medicus Ltd by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #977 globally with a market cap of $27.15 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2152 globally with a market cap of $10.63 Billion USD.
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2586 globally with a market cap of $8.25 Billion USD.
- HealthEquity Inc (NASDAQ:HQY): Ranked #2845 globally with a market cap of $7.17 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #977 | Veeva Systems Inc Class A | NYSE:VEEV | $27.15 Billion | $178.72 |
| #2152 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $60.88 |
| #2586 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $8.25 Billion | $47.51 |
| #2845 | HealthEquity Inc | NASDAQ:HQY | $7.17 Billion | $85.21 |
Pro Medicus Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Pro Medicus Ltd's market cap moved from $236.64 Million to $ 11.80 Billion, with a yearly change of 44.65%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$11.80 Billion | -27.73% |
| 2025 | AU$16.33 Billion | -11.69% |
| 2024 | AU$18.49 Billion | +161.84% |
| 2023 | AU$7.06 Billion | +74.19% |
| 2022 | AU$4.05 Billion | -11.11% |
| 2021 | AU$4.56 Billion | +83.31% |
| 2020 | AU$2.49 Billion | +53.66% |
| 2019 | AU$1.62 Billion | +106.06% |
| 2018 | AU$785.65 Million | +25.55% |
| 2017 | AU$625.75 Million | +83.18% |
| 2016 | AU$341.61 Million | +44.36% |
| 2015 | AU$236.64 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 4th, 2026 the market cap of Pro Medicus Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $11.80 Billion USD |
| MoneyControl | $11.80 Billion USD |
| MarketWatch | $11.80 Billion USD |
| marketcap.company | $11.80 Billion USD |
| Reuters | $11.80 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Pro Medicus Ltd
Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiol… Read more